InterCure Ltd. congratulated the Federal Republic of Germany for the passing of the ?CannG? Cannabis Act, which is expected to take effect on April 1, 2024. On the backdrop of this monumental development, InterCure expects to launch a series of products in Germany in the coming months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,225 ILa | -1.29% | +6.71% | +164.52% |
01/05 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
01/05 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+164.52% | 150M | |
-.--% | 339M | |
+34.02% | 276M | |
+33.33% | 261M | |
+39.53% | 182M | |
-33.33% | 137M | |
+50.41% | 136M | |
-28.57% | 121M | |
-7.69% | 80.3M | |
+100.00% | 60.26M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months